Authors:
POPLIN EA
JACOBSON J
HERSKOVIC A
PANELLA TJ
VALDIVIESO M
HUTCHINS LF
MACDONALD JS
Citation: Ea. Poplin et al., EVALUATION OF MULTIMODALITY TREATMENT OF LOCOREGIONAL ESOPHAGEAL-CARCINOMA BY SOUTHWEST-ONCOLOGY-GROUP-9060, Cancer, 78(9), 1996, pp. 1851-1856
Authors:
MITTAL BB
ZIMMER MA
SATHIASEELAN V
BENSON AB
MITTAL RR
DUTTA S
ROSEN ST
SPIES SM
METTLER JM
GROCH MW
Citation: Bb. Mittal et al., PHASE I II TRIAL OF COMBINED I-131 ANTI-CEA MONOCLONAL-ANTIBODY AND HYPERTHERMIA IN PATIENTS WITH ADVANCED COLORECTAL ADENOCARCINOMA/, Cancer, 78(9), 1996, pp. 1861-1870
Citation: K. Sugihara et al., PELVIC AUTONOMIC NERVE PRESERVATION FOR PATIENTS WITH RECTAL-CARCINOMA - ONCOLOGIC AND FUNCTIONAL OUTCOME, Cancer, 78(9), 1996, pp. 1871-1880
Citation: Cs. Lee, DIFFERENCES IN CELL-PROLIFERATION AND PROGNOSTIC-SIGNIFICANCE OF PROLIFERATING CELL NUCLEAR ANTIGEN AND KI-67 ANTIGEN IMMUNOREACTIVITY IN IN-SITU AND INVASIVE CARCINOMAS OF THE EXTRAHEPATIC BILIARY-TRACT, Cancer, 78(9), 1996, pp. 1881-1887
Authors:
RUBIN J
GALLAGHER JG
SCHROEDER G
SCHUTT AJ
DALTON RJ
KUGLER JW
MORTON RF
MAILLIARD JA
BURCH PA
Citation: J. Rubin et al., PHASE-II TRIALS OF 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC GASTRIC OR PANCREATIC-CARCINOMA, Cancer, 78(9), 1996, pp. 1888-1891
Citation: T. Fujisawa et Y. Yamaguchi, POSTOPERATIVE IMMUNOSTIMULATION AFTER COMPLETE RESECTION IMPROVES SURVIVAL OF PATIENTS WITH STAGE-I NONSMALL CELL LUNG-CARCINOMA, Cancer, 78(9), 1996, pp. 1892-1898
Authors:
CONZEN SD
KAUFMAN PA
ARVIZU C
LEMARBRE P
MAURER LH
MOTT LA
MILLS LE
Citation: Sd. Conzen et al., PHASE-II TRIAL OF TAMOXIFEN, ETOPOSIDE, MITOXANTRONE, AND CISPLATIN IN PATIENTS WITH METASTATIC BREAST-CARCINOMA, Cancer, 78(9), 1996, pp. 1906-1911
Authors:
GAGE I
SCHNITT SJ
NIXON AJ
SILVER B
RECHT A
TROYAN SL
EBERLEIN T
LOVE SM
GELMAN R
HARRIS JR
CONNOLLY JL
Citation: I. Gage et al., PATHOLOGICAL MARGIN INVOLVEMENT AND THE RISK OF RECURRENCE IN PATIENTS TREATED WITH BREAST-CONSERVING THERAPY, Cancer, 78(9), 1996, pp. 1921-1928
Authors:
TSUKAMOTO K
ITO N
YOSHIMOTO M
IWASE T
TADA T
KASUMI F
NAKAMURA Y
EMI M
Citation: K. Tsukamoto et al., 2 DISTINCT COMMONLY DELETED REGIONS ON CHROMOSOME 13Q SUGGEST INVOLVEMENT OF BRCA2 AND RETINOBLASTOMA GENES IN SPORADIC BREAST CARCINOMAS, Cancer, 78(9), 1996, pp. 1929-1934
Authors:
NORDSTROM B
STRANG P
BERGSTROM R
NILSSON S
TRIBUKAIT B
Citation: B. Nordstrom et al., A COMPARISON OF PROLIFERATION MARKERS AND THEIR PROGNOSTIC VALUE FOR WOMEN WITH ENDOMETRIAL CARCINOMA - KI-67, PROLIFERATING CELL NUCLEAR ANTIGEN, AND FLOW CYTOMETRIC S-PHASE FRACTION, Cancer, 78(9), 1996, pp. 1942-1951
Authors:
WANG HM
NG SH
WANG CH
LIAW CC
TSAI GM
LAI GM
Citation: Hm. Wang et al., CORRELATION BETWEEN COMPUTED TOMOGRAPHIC DENSITY OF LYMPH-NODE METASTASES AND RESPONSE TO CISPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA IN AN AREA IN WHICH BETEL QUID CHEWING IS PREVALENT, Cancer, 78(9), 1996, pp. 1972-1979
Citation: E. Raymond et al., LOGISTIC-REGRESSION MODEL OF FOTEMUSTINE TOXICITY COMBINING INDEPENDENT PHASE-II STUDIES, Cancer, 78(9), 1996, pp. 1980-1987
Authors:
SCHWARTZ GK
CHRISTMAN K
SALTZ L
CASPER E
QUAN V
BERTINO J
MARTIN DS
COLOFIORE J
Citation: Gk. Schwartz et al., A PHASE-I TRIAL OF A MODIFIED, DOSE-INTENSIVE FAMTX REGIMEN (HIGH-DOSE 5-FLUOROURACIL PLUS DOXORUBICIN PLUS HIGH-DOSE METHOTREXATE PLUS LEUCOVORIN) WITH ORAL URIDINE RESCUE, Cancer, 78(9), 1996, pp. 1988-1995
Authors:
BLANK RD
SKLAR CA
DIMICH A
LAQUAGLIA MP
BRENNAN MF
Citation: Rd. Blank et al., CLINICAL PRESENTATIONS AND RET PROTOONCOGENE MUTATIONS IN 7 MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 KINDREDS, Cancer, 78(9), 1996, pp. 1996-2003